Case Studies , Drug Substance , API Development

Case Study: API Development

24 October 2025
Overview

A US biotech developing combined small molecule and biologic immunotherapies partnered with us for our API development expertise.

This study highlights our rapid development of a scalable synthesis route for a new drug substance analogue and determination of the most suitable salt form for formulation.

Download a copy of our API development case study today and contact our experts to find out even more.

 

Download
Date
24 October 2025
Contact Us
Discuss your next programme with us today.